EMA gives nod to pre-filled syringe form of Eylea
Bayer announces that the product will be made available through ‘efficient and convenient’ drug delivery method in Europe.
Bayer announces that the product will be made available through ‘efficient and convenient’ drug delivery method in Europe.
The accelerator for cell and gene therapy startups reveals the closure of its second financing round and how the funds will be used.
The CMO expands its Sterling site to add new office space, as well as expanding manufacturing space and supporting services.